Henderson Jane, Apogee Therapeutics CFO, sells $170k in stock
#Apogee Therapeutics #Henderson Jane #CFO #stock sale #regulatory filing #executive transactions #biotechnology
📌 Key Takeaways
- Apogee Therapeutics CFO Henderson Jane sold $170,000 worth of company stock.
- The sale was disclosed in a recent regulatory filing.
- Such transactions are common among executives for personal financial management.
- The sale does not necessarily indicate a negative outlook on the company.
🏷️ Themes
Executive Stock Sale, Corporate Finance
Entity Intersection Graph
No entity connections available yet for this article.